About Siri Atma Greeley MD, PhD
In his current research, Dr. Greeley hopes to shed light on the spectrum of diabetes in childhood. His focus is on monogenic diabetes (diabetes caused by a single gene mutation), which can be difficult to distinguish from the more common types. Neonatal diabetes that occurs in the first few months of life commonly has an underlying monogenic cause and can often be treated with pills instead of insulin (http://kovlerdiabetescenter.org/registry). Dr. Greeley is helping to establish the University of Chicago as a national center for the study of monogenic diabetes.
Noorchashm H, Lieu YK, Song HK, et al. B lymphocytes influence the shape of the mature preimmune CD4+ TCR repertoire. Transplant Proc. 1999;31(1-2):832-3.
Financial Disclosures for Siri Atma Greeley MD, PhD
EndocrineWeb, a Vertical Health, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy.
To help achieve this goal, EndocrineWeb requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.
The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.